213 related articles for article (PubMed ID: 14767830)
1. Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine.
Hastings MD; Porter KM; Maguire JD; Susanti I; Kania W; Bangs MJ; Sibley CH; Baird JK
J Infect Dis; 2004 Feb; 189(4):744-50. PubMed ID: 14767830
[TBL] [Abstract][Full Text] [Related]
2. Antifolates can have a role in the treatment of Plasmodium vivax.
Hawkins VN; Joshi H; Rungsihirunrat K; Na-Bangchang K; Sibley CH
Trends Parasitol; 2007 May; 23(5):213-22. PubMed ID: 17368986
[TBL] [Abstract][Full Text] [Related]
3. Molecular assessment of dhfr/dhps mutations among Plasmodium vivax clinical isolates after introduction of sulfadoxine/pyrimethamine in combination with artesunate in Iran.
Afsharpad M; Zakeri S; Pirahmadi S; Djadid ND
Infect Genet Evol; 2012 Jan; 12(1):38-44. PubMed ID: 22020253
[TBL] [Abstract][Full Text] [Related]
4. Molecular markers of in vivo Plasmodium vivax resistance to amodiaquine plus sulfadoxine-pyrimethamine: mutations in pvdhfr and pvmdr1.
Marfurt J; de Monbrison F; Brega S; Barbollat L; Müller I; Sie A; Goroti M; Reeder JC; Beck HP; Picot S; Genton B
J Infect Dis; 2008 Aug; 198(3):409-17. PubMed ID: 18582193
[TBL] [Abstract][Full Text] [Related]
5. Distribution of Plasmodium vivax pvdhfr and pvdhps alleles and their association with sulfadoxine-pyrimethamine treatment outcomes in Indonesia.
Asih PB; Marantina SS; Nababan R; Lobo NF; Rozi IE; Sumarto W; Dewi RM; Tuti S; Taufik AS; Mulyanto ; Sauerwein RW; Syafruddin D
Malar J; 2015 Sep; 14():365. PubMed ID: 26395428
[TBL] [Abstract][Full Text] [Related]
6. Multiple origins of resistance-conferring mutations in Plasmodium vivax dihydrofolate reductase.
Hawkins VN; Auliff A; Prajapati SK; Rungsihirunrat K; Hapuarachchi HC; Maestre A; O'Neil MT; Cheng Q; Joshi H; Na-Bangchang K; Sibley CH
Malar J; 2008 Apr; 7():72. PubMed ID: 18442404
[TBL] [Abstract][Full Text] [Related]
7. Plasmodium vivax dihydrofolate reductase point mutations from the Indian subcontinent.
Kaur S; Prajapati SK; Kalyanaraman K; Mohmmed A; Joshi H; Chauhan VS
Acta Trop; 2006 Feb; 97(2):174-80. PubMed ID: 16310156
[TBL] [Abstract][Full Text] [Related]
8. Novel Plasmodium vivax dhfr alleles from the Indonesian Archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system.
Hastings MD; Maguire JD; Bangs MJ; Zimmerman PA; Reeder JC; Baird JK; Sibley CH
Antimicrob Agents Chemother; 2005 Feb; 49(2):733-40. PubMed ID: 15673758
[TBL] [Abstract][Full Text] [Related]
9. Island-wide diversity in single nucleotide polymorphisms of the Plasmodium vivax dihydrofolate reductase and dihydropteroate synthetase genes in Sri Lanka.
Schousboe ML; Rajakaruna RS; Salanti A; Hapuarachchi HC; Galappaththy GN; Bygbjerg IC; Amerasinghe PH; Konradsen F; Alifrangis M
Malar J; 2007 Mar; 6():28. PubMed ID: 17349045
[TBL] [Abstract][Full Text] [Related]
10. Change in mutation patterns of Plasmodium vivax dihydrofolate reductase (Pvdhfr) and dihydropteroate synthase (Pvdhps) in P. vivax isolates from malaria endemic areas of Thailand.
Kuesap J; Rungsrihirunrat K; Thongdee P; Ruangweerayut R; Na-Bangchang K
Mem Inst Oswaldo Cruz; 2011 Aug; 106 Suppl 1():130-3. PubMed ID: 21881767
[TBL] [Abstract][Full Text] [Related]
11. High prevalence and fixation of Plasmodium vivax dhfr/dhps mutations related to sulfadoxine/pyrimethamine resistance in French Guiana.
Barnadas C; Musset L; Legrand E; Tichit M; Briolant S; Fusai T; Rogier C; Bouchier C; Picot S; Ménard D
Am J Trop Med Hyg; 2009 Jul; 81(1):19-22. PubMed ID: 19556560
[TBL] [Abstract][Full Text] [Related]
12. Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum.
Biswas S
J Postgrad Med; 2004; 50(1):17-20. PubMed ID: 15047993
[TBL] [Abstract][Full Text] [Related]
13. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations.
Tjitra E; Baker J; Suprianto S; Cheng Q; Anstey NM
Antimicrob Agents Chemother; 2002 Dec; 46(12):3947-53. PubMed ID: 12435700
[TBL] [Abstract][Full Text] [Related]
15. Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs.
Auliff A; Wilson DW; Russell B; Gao Q; Chen N; Anh le N; Maguire J; Bell D; O'Neil MT; Cheng Q
Am J Trop Med Hyg; 2006 Oct; 75(4):617-21. PubMed ID: 17038682
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity to antifolates and genetic analysis of Plasmodium vivax isolates from Thailand.
Rungsihirunrat K; Na-Bangchang K; Hawkins VN; Mungthin M; Sibley CH
Am J Trop Med Hyg; 2007 Jun; 76(6):1057-65. PubMed ID: 17556611
[TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
Tahar R; Basco LK
Acta Trop; 2007 Aug; 103(2):81-9. PubMed ID: 17640607
[TBL] [Abstract][Full Text] [Related]
18. Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum.
Alam MT; Bora H; Bharti PK; Saifi MA; Das MK; Dev V; Kumar A; Singh N; Dash AP; Das B; Wajihullah ; Sharma YD
Antimicrob Agents Chemother; 2007 Mar; 51(3):857-63. PubMed ID: 17194833
[TBL] [Abstract][Full Text] [Related]
19. Limited polymorphism in the dihydropteroate synthetase gene (dhps) of Plasmodium vivax isolates from Thailand.
Imwong M; Pukrittayakamee S; Cheng Q; Moore C; Looareesuwan S; Snounou G; White NJ; Day NP
Antimicrob Agents Chemother; 2005 Oct; 49(10):4393-5. PubMed ID: 16189131
[TBL] [Abstract][Full Text] [Related]
20. A novel Plasmodium falciparum expression system for assessing antifolate resistance caused by mutant P. vivax dihydrofolate reductase-thymidylate synthase.
O'Neil MT; Korsinczky ML; Gresty KJ; Auliff A; Cheng Q
J Infect Dis; 2007 Aug; 196(3):467-74. PubMed ID: 17597462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
